Stay updated on Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial for gastric cancer and the addition of collaborators and a new revision number. The principal investigator's name has also been updated.SummaryDifference47%
- Check66 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.